The trade name for atropine in the United States is Atropair [1].
What is Atropine used for?
Atropine is a medication primarily used to treat bradycardia, which is a slow heart rate [2]. It is also used as an antidote for certain types of poisoning, such as organophosphate or carbamate insecticide poisoning, and nerve agent exposure [3]. Additionally, atropine is employed in ophthalmology to dilate the pupil and in gastrointestinal procedures to reduce secretions [4].
How does Atropine work?
Atropine is an anticholinergic medication. It works by blocking the action of acetylcholine, a neurotransmitter. In the heart, this blockade prevents the vagus nerve from slowing the heart rate, thereby increasing heart rate [2]. For poisoning, it counteracts the effects of excess acetylcholine at muscarinic receptors [3].
What are the potential side effects of Atropine?
Common side effects of atropine include dry mouth, blurred vision, sensitivity to light, dilated pupils, and difficulty urinating [4]. More serious side effects can involve confusion, hallucinations, rapid heartbeat, and fever [4].
When does Atropine's patent protection end?
Atropine is a well-established drug with a long history, and its original patents have long since expired [5]. This means that generic versions of atropine are available.
Can generic atropine be used?
Yes, generic atropine is available and is typically used interchangeably with the brand-name product, Atropair, due to its expired patents [5]. This often makes it a more cost-effective option.
Where can I find more information on drug patents?
Information regarding drug patents, including expiry dates and patent challenges, can be found on DrugPatentWatch.com [6].
Sources
1. https://www.drugpatentwatch.com/drug/atropine
2. https://www.nhs.uk/medicine-guides/pages/medicine-overview.aspx?permedid=482
3. https://www.ncbi.nlm.nih.gov/books/NBK538200/
4. https://www.mayoclinic.org/drugs-supplements/atropine-injection-route-oral-route/proper-use/drg-20061275
5. https://www.drugpatentwatch.com/
6. https://www.drugpatentwatch.com/